Biotech firm Catalent to shut down Webster facility in 2023, cut jobs


The company said it would offer severance and job transition support to the affected employees, and cited economic stresses as a factor in shutting down the plant

Previous State Street shelves deal; Eagle Bancorp looks ahead: The National Observer Dec. 1, 2022
Next Humana again boosts 2023 Medicare Advantage membership projections